UBS Group’s IsoPlexis Corporation Common Stock ISO Stock Holding History

UBS Group’s Portfolio ISO Stock Details ISO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-4,747	Closed	-$7.36K	–	11281
2022 Q4	$7.36K	Sell	4,747 -883	-16%	-$1.33K	﹤0.01%	8902
2022 Q3	$10K	Buy	5,630 +4,567	+430%	+$11.3K	﹤0.01%	8523
2022 Q2	$2K	Sell	1,063 -1,132	-52%	-$2.63K	﹤0.01%	9731
2022 Q1	$8K	Sell	2,195 -1,343	-38%	-$7.77K	﹤0.01%	8756
2021 Q4	$33K	Buy	+3,538	New	+$39.2K	﹤0.01%	7315

UBS Group's ISO Position: Q1 2023 in Review

UBS Group sold out of IsoPlexis Corporation Common Stock (ISO) in Q1 2023, closing a stake of 4,747 shares — an estimated $7.36K sold.

UBS Group first reported a position in ISO in Q4 2021 and held it in 5 quarters. The position peaked at $33K in Q4 2021. 0 funds tracked by Wall St. Rank hold ISO as of Q1 2023.

UBS Group reported no remaining IsoPlexis Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
UBS Group sold 4,747 IsoPlexis Corporation Common Stock shares in Q1 2023, an estimated $7.36K.
UBS Group first reported a position in IsoPlexis Corporation Common Stock in Q4 2021 and held it in 5 quarters.
UBS Group's IsoPlexis Corporation Common Stock position peaked at $33K in Q4 2021.
0 funds tracked by Wall St. Rank held IsoPlexis Corporation Common Stock as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.